Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Actinium Pharmaceuticals ( (ATNM) ) just unveiled an announcement.
Actinium Pharmaceuticals, Inc. held its 2024 annual stockholder meeting where Sandesh Seth and Jeffrey W. Chell were re-elected as Class II directors to serve until 2027. Additionally, Marcum LLP was ratified as the independent public accountant for the fiscal year 2024. The meeting saw the participation of 19,724,287 shares, with all proposals receiving approval from stockholders.
For a thorough assessment of ATNM stock, go to TipRanks’ Stock Analysis page.
